C. H. To
Author pages are created from data sourced from our academic publisher partnerships and public sources.
Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis
- C. C. Mok, G. Ko, L. Ho, K. Yu, P. T. Chan, C. H. To
- Arthritis care & research
- 1 February 2011
To evaluate the prevalence of the metabolic syndrome in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA).
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
BACKGROUND Tacrolimus is a relatively new calcineurin inhibitor that has been increasingly used in transplant medicine. The objective of the current work is to report our preliminary experience with… Expand
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for the initial therapy of lupus nephritis (LN). Study design This is an open randomised controlled parallel… Expand
Long-term Survival of Southern Chinese Patients With Systemic Lupus Erythematosus: A Prospective Study of All Age-Groups
Abstract: We conducted the current study to determine the clinical determinants of survival and the survival rates in an unselected cohort of Chinese patients with new-onset systemic lupus… Expand
Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica.
Neuromyelitis optica (NMO), or Devic's disease, is an aggressive inflammatory disease of the central nervous system that predominantly affects the optic nerves and the spinal cord. The association… Expand
Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
OBJECTIVES To report the efficacy of prednisolone and azathioprine (AZA) in the treatment of systemic lupus erythematosus (SLE)-related protein-losing gastroenteropathy (PLGE). METHODS Between 1995… Expand
Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus
Objectives: To study the annual incidence and standardized incidence ratio (SIR) of cerebrovascular accident (CVA) in patients with systemic lupus erythematosus (SLE). Subjects and methods: The… Expand
Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study
Objectives To evaluate the immunogenicity and safety of GARDASIL, a quadrivalent human papillomavirus (HPV) vaccine, in patients with systemic lupus erythematosus (SLE). Methods Women with SLE aged… Expand
Rituximab for refractory polymyositis: an open-label prospective study.
OBJECTIVE To report the efficacy and toxicity of rituximab in the treatment of refractory polymyositis. METHODS Adult patients with active polymyositis as evidenced by persistent proximal muscle… Expand
Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups
Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups A Mak, CC Mok, WP Chu, CH To, SN Wong and TC Au Please note that the following pdf is a corrected version… Expand